Every patient seeking your insight requires a smarter path to personalized care. And today, there’s no imaging technology better designed to help you than PET/CT. With our latest innovation, Discovery* IQ1, we offer a platform that is increasingly sensitive to detecting small forms of disease and delivers consistent quantitative measurements so you can trust what you see, making it an essential tool for providing personalized care from disease detection through treatment assessment.
1. 510(k) pending at FDA. Not available for sale in the United States. Not available for sale in all regions.